Bambuterol, a long-acting beta-2 agonist (LABA), is a critical medication in respiratory healthcare, used primarily to manage symptoms of asthma and chronic obstructive pulmonary disease (COPD). With over 339 million people globally affected by asthma and 251 million by COPD (WHO, 2023), demand for Bambuterol remains steady, making it a priority for pharmaceutical suppliers. However, navigating global procurement can be complex. This article provides strategies to compile and leverage a Bambuterol Global Buyers List, empowering suppliers to connect with international purchasers effectively. 1. What is Bambuterol and Why is It in High Demand? Bambuterol is a bronchodilator that relaxes airway muscles, improving breathing for individuals with asthma or COPD. As…